Teva enlarges workforce for first time since 2016
The Israeli pharmaceutical company had 36,472 employees at the end of 2023, up 3.8% from 2022, as Teva returns to growth.
Source: globes.co.il
Stay updated with breaking news from Kare Schulz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Israeli pharmaceutical company had 36,472 employees at the end of 2023, up 3.8% from 2022, as Teva returns to growth.
The Israeli pharmaceutical company's share price has risen 50% over the past six months but is still 80% down on its peak in 2015.
Teva Pharmaceutical's undoing was its $40.5B deal to acquire Allergan's generic drug business in 2015. Read why TEVA's 56% run in the stock price makes it a Sell.